Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Antimicrobial Resistance Diagnostics Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?#_x000D_
The antimicrobial resistance diagnostics market size has shown strong growth in recent years. It is anticipated to increase from $4.41 billion in 2025 to $4.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. The expansion witnessed during the historical period can be attributed to the rising occurrence of antibiotic-resistant infections, the reliance on traditional culture-based diagnostics, an increase in hospital-acquired infections, growing consciousness of antimicrobial stewardship, and the broadening of clinical microbiology laboratories._x000D_
_x000D_
The antimicrobial resistance diagnostics market is projected to experience robust expansion over the coming years. This market is anticipated to reach $6.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth during the forecast period include progress in PCR and NGS diagnostic technologies, an increase in government funding for AMR surveillance initiatives, greater uptake of rapid diagnostic tests, expansion in pharmaceutical and biotechnology research, and the incorporation of data-driven decision support systems. Key trends expected over the forecast period encompass a surge in the adoption of rapid and point-of-care AMR diagnostics, increasing need for targeted and personalized antimicrobial treatments, enhanced monitoring of drug-resistant pathogens, the broadening of molecular and genomic diagnostic testing, and the reinforcement of hospital infection control and stewardship programs._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Antimicrobial Resistance Diagnostics Market Growth Backed By Core Demand Fundamentals#_x000D_
The increasing occurrence of drug-resistant infections is projected to stimulate the expansion of the antimicrobial resistance diagnostics market in the future. These infections arise when microorganisms like bacteria, viruses, fungi, or parasites develop ways to withstand medicines that previously worked, rendering conventional treatments ineffective and infections more difficult to manage. The escalating spread of drug-resistant infections stems from the excessive use of antibiotics in farming, where small amounts of antimicrobials are regularly incorporated into animal feed, fostering resistance that can transfer to humans via the food chain. Tools for antimicrobial resistance diagnostics, including quick genetic tests and culture-dependent sensitivity evaluations, are crucial in tackling the rising incidence of drug-resistant infections. They do this by allowing prompt detection of resistant microbes, directing specific treatments, and cutting down on the inappropriate use of wide-spectrum antibiotics. For example, in November 2024, the UK Health Security Agency (UKHSA), a government body located in the UK, indicated that severe antibiotic-resistant infections in England climbed from 58,224 in 2022 to an approximate 66,730 in 2023, concurrently with a rise in antibiotic usage to 2.4% in 2023 from 2022. Consequently, the increasing occurrence of drug-resistant infections is fueling the expansion of the antimicrobial resistance diagnostics market._x000D_
_x000D_
#Antimicrobial Resistance Diagnostics Market Breakdown By Product Type And Application#_x000D_
The antimicrobial resistance diagnostics market covered in this report is segmented – _x000D_
_x000D_
1) By Product Type: Kits And Reagents, Instruments And Consumables_x000D_
2) By Pathogen: Drug-Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRntS), Other Pathogens_x000D_
3) By Technology: Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), Mass Spectrometry, Rapid And Point Of Care, Other Technologies_x000D_
4) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Kits And Reagents: Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Polymerase Chain Reaction (PCR) Reagents, Immunoassay Reagents, Stains And Dyes, Culture Media_x000D_
2) By Instruments And Consumables: Polymerase Chain Reaction (PCR) Machines, Ultraviolet-Visible (UV-Vis) Spectrophotometers, Next-Generation Sequencing (NGS) Systems, Microarray Scanners, Automated Liquid Handlers, Sample Collection Tubes And Swabs_x000D_
_x000D_
#Antimicrobial Resistance Diagnostics Market Growth Trends Reshaping The Competitive Landscape#_x000D_
Leading firms within the antimicrobial resistance (AMR) diagnostics market are increasingly utilizing cutting-edge technologies, including point-of-care antimicrobial-susceptibility testing (AST) solutions, to boost the rapidity and accuracy of diagnostics and improve antimicrobial-stewardship results. Point-of-care antimicrobial-susceptibility testing (AST) encompasses swift, patient-proximate examinations designed to pinpoint effective antibiotics for specific infections, thereby enabling healthcare professionals to promptly select appropriate and targeted treatments. An example of this trend is Sysmex Corporation, a Japan-based developer of in-vitro diagnostic solutions, which introduced its PA-100 AST System in June 2023. This rapid point-of-care AST platform is engineered to identify bacterial presence and assess antimicrobial susceptibility in urine samples in approximately 30 minutes. The system incorporates microfluidic single-cell analysis, offers near-patient testing capabilities, and provides automated reporting of susceptibility results. This PA-100 AST System enhances clinical decision-making processes, aids in reducing superfluous antibiotic prescriptions, and facilitates prompt, directed treatment strategies to combat antimicrobial resistance._x000D_
_x000D_
#Antimicrobial Resistance Diagnostics Market Leading Companies And Competitive Benchmarking#_x000D_
Major companies operating in the antimicrobial resistance diagnostics market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Becton Dickinson And Company, bioMerieux SA, Sysmex Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Seegene Inc, Alifax S r l, Accelerate Diagnostics Inc, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc, OpGen Inc, T2 Biosystems, Jiangsu Medomics Medical Technology Co Ltd, Cepheid, Luminex Corporation, Bruker Corporation, Hologic Inc _x000D_
_x000D_
#View The Full Antimicrobial Resistance Diagnostics Market Report:#_x000D_
_x000D_
#Antimicrobial Resistance Diagnostics Market Largest Region By Revenue And Market Share#_x000D_
North America was the largest region in the antimicrobial resistance diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
